Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05598931 · ClinicalTrials.gov registry record
Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRI
A clinical trial, sponsored by Soterix Medical.
- Completed
- Registry status
- 20
- Enrollment target
NCT05598931: Completed study, sponsored by Soterix Medical.
NCT05598931 is a clinical trial that has completed, run by Soterix Medical. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05598931 has completed, sponsored by Soterix Medical.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Healthy controls (HC) will be studied once to provide data needed to validate the virtual neuro-navigation system. All subjects will undergo a single MRI session and will then participate in an on-line neuro-navigation session in which various TMS coil positions will be recorded. The brain/head images will be provided to the programmer to permit development of the virtual neuro-navigation algorithm. Data from Yr1 will be used by the programmer as a training sample, and from Yr2 as a test sample.
Primary Outcome
MRI based brain coordinates will be determined using newly developed neuronavigation software
Interventions
- DEVICE Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2024-10-01 |
What the finished NCT05598931 record still lists
NCT05598931 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.
NCT05598931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05598931 about?
NCT05598931 is a clinical study titled "Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRI". Healthy controls (HC) will be studied once to provide data needed to validate the virtual neuro-navigation system. All subjects will undergo a single MRI session and will then participate in an on-line neuro-navigation session in which various TMS coil positions will be recorded. The brain/head imag...
What is the current status of trial NCT05598931?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-07-01. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT05598931?
The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05598931?
This trial is sponsored by Soterix Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI